An Open-Label, Multi-Center Study Employing a Targeted 6-MWT Distance Threshold Approach to Guide Bosentan-Based Therapy and to Assess the Utility of MRI on Cardiac Remodeling (COMPASS 3)
An Open-Label, Multi-Center Study Employing a Targeted 6-MWT Distance Threshold Approach to Guide Bosentan-Based Therapy and to Assess the Utility of MRI on Cardiac Remodeling (COMPASS 3)
This trial is a multicenter open-label, phase 4 trial to determine the percentage of patients that achieve a target 6 MWT distance threshold utilizing a bosentan-based, stepped approach to therapy.
PATIENTS WITH PULMONARY HYPERTENSION
YES
William J. Gibbons, MD - Principal Investigator Sub- Investigator - Susan P. Graham, MD Sub-Investigator - Eileen Daetsch, NP
Name: MARY BONORA
Phone: 716.859.4641
Email: MBONORA@KALEIDAHEALTH.ORG